These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9821074)

  • 1. Expression of bcl-2, p53 and Ki-67 in arsenical skin cancers.
    Chang CH; Tsai RK; Chen GS; Yu HS; Chai CY
    J Cutan Pathol; 1998 Oct; 25(9):457-62. PubMed ID: 9821074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.
    Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR
    Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sun-exposure- and aging-dependent p53 protein accumulation results in growth advantage for tumour cells in carcinogenesis of nonmelanocytic skin cancer.
    Liang SB; Ohtsuki Y; Furihata M; Takeuchi T; Iwata J; Chen BK; Sonobe H
    Virchows Arch; 1999 Mar; 434(3):193-9. PubMed ID: 10190297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of cell survival and cell cycle regulatory proteins in cutaneous squamoproliferative lesions.
    Wrone-Smith T; Bergstrom J; Quevedo ME; Reddy V; Gutierrez-Steil C; Nickoloff BJ
    J Dermatol Sci; 1999 Jan; 19(1):53-67. PubMed ID: 9890376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of promyelocytic leukaemia protein in Bowen's disease, skin squamous cell carcinoma and basal cell carcinoma].
    Wang Q; Ma H; Wang S; Ma Y; Zou X; Li R
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jul; 33(7):1075-7. PubMed ID: 23895857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell proliferation and p53 protein expressions in cutaneous epithelial neoplasms.
    Onodera H; Nakamura S; Sugai T
    Am J Dermatopathol; 1996 Dec; 18(6):580-8. PubMed ID: 8989929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 expression and proliferative activity in Bowen's disease with or without chronic arsenic exposure.
    Kuo TT; Hu S; Lo SK; Chan HL
    Hum Pathol; 1997 Jul; 28(7):786-90. PubMed ID: 9224745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of skin-associated lymphoid tissue in the carcinogenesis of arsenical skin cancer.
    Yu HS; Chen GS; Sheu HM; Kao JS; Chang KL; Yu CL
    Proc Natl Sci Counc Repub China B; 1992 Jan; 16(1):17-22. PubMed ID: 1385879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of cyclin D1 in nonmelanocytic skin cancer.
    Liang SB; Furihata M; Takeuchi T; Iwata J; Chen BK; Sonobe H; Ohtsuki Y
    Virchows Arch; 2000 Apr; 436(4):370-6. PubMed ID: 10834541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of mitogenic responses of mononuclear cells by arsenic in arsenical skin cancers.
    Yu HS; Chang KL; Wang CM; Yu CL
    J Dermatol; 1992 Nov; 19(11):710-4. PubMed ID: 1293158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of cyclooxygenase-2 and p53 expression in skin tumors.
    Kim KH; Park EJ; Seo YJ; Cho HS; Kim CW; Kim KJ; Park HR
    J Dermatol; 2006 May; 33(5):319-25. PubMed ID: 16700663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strong expression of a longevity-related protein, SIRT1, in Bowen's disease.
    Hida Y; Kubo Y; Murao K; Arase S
    Arch Dermatol Res; 2007 May; 299(2):103-6. PubMed ID: 17180656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of P27, Ki67 and P53 in squamous cell carcinoma, actinic keratosis and Bowen disease.
    Talghini S; Halimi M; Baybordi H
    Pak J Biol Sci; 2009 Jun; 12(12):929-33. PubMed ID: 19777788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
    Sakiz D; Turkmenoglu TT; Kabukcuoglu F
    Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis and cellular proliferation in human epidermal squamous cell neoplasia.
    Makino T; Tatebe S; Goto A; Mihara M; Ito H
    J Cutan Pathol; 1998 Mar; 25(3):136-42. PubMed ID: 9550311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous manifestations of chronic arsenicism: review of seventeen cases.
    Wong SS; Tan KC; Goh CL
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):179-85. PubMed ID: 9486671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
    Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
    Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of L-type amino acid transporter 1 in various skin lesions.
    Hirano K; Uno K; Kuwabara H; Kojima K; Ohno S; Sakurai H; Kamma H; Kurata A
    Pathol Res Pract; 2014 Oct; 210(10):634-9. PubMed ID: 24939142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ΔNp63 promotes abnormal epidermal proliferation in arsenical skin cancers.
    Lu JH; Liao WT; Lee CH; Chang KL; Ke HL; Yu HS
    Toxicol In Vitro; 2018 Dec; 53():57-66. PubMed ID: 30026126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.